Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 4,324 | 3,331 | 16,603 | 0 |
| Operating Income | -4,324 | -3,331 | -16,603 | N/A |
| Other Income | 99 | 103 | 48 | 0 |
| Pre-tax Income | -4,225 | -3,228 | -16,555 | 0 |
| Net Income Continuous | -4,225 | -3,228 | -16,555 | N/A |
| Net Income | $-4,225 | $-3,228 | $-16,555 | $N/A |
| EPS Basic Total Ops | -2.25 | -1.75 | -9.45 | N/A |
| EPS Basic Continuous Ops | -2.27 | -1.74 | -9.43 | N/A |
| EPS Diluted Total Ops | -2.25 | -1.75 | -9.45 | N/A |
| EPS Diluted Continuous Ops | -2.27 | -1.74 | -9.43 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.25 | N/A | N/A | N/A |
| EBITDA(a) | $-4,324 | $-3,331 | $-16,603 | $N/A |